BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9393875)

  • 1. AU-rich mRNA instability elements on human papillomavirus type 1 late mRNAs and c-fos mRNAs interact with the same cellular factors.
    Sokolowski M; Zhao C; Tan W; Schwartz S
    Oncogene; 1997 Nov; 15(19):2303-19. PubMed ID: 9393875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Okadaic acid-mediated induction of the c-fos gene in estrogen receptor-negative human breast carcinoma cells utilized, in part, posttranscriptional mechanisms involving adenosine-uridine-rich elements.
    Farhana L; Boyanapalli M; Tschang SH; Sun RJ; Hsu CK; Zhang YX; Fontana JA; Rishi AK
    Cell Growth Differ; 2000 Oct; 11(10):541-50. PubMed ID: 11063127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of adenosine-uridine-rich RNA binding factors.
    Nakamaki T; Imamura J; Brewer G; Tsuruoka N; Koeffler HP
    J Cell Physiol; 1995 Dec; 165(3):484-92. PubMed ID: 7593227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AU-rich 3' untranslated region of human MDR1 mRNA is an inefficient mRNA destabilizer.
    Prokipcak RD; Raouf A; Lee C
    Biochem Biophys Res Commun; 1999 Aug; 261(3):627-34. PubMed ID: 10441477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-fos mRNA instability determinants present within both the coding and the 3' non coding region link the degradation of this mRNA to its translation.
    Veyrune JL; Carillo S; Vié A; Blanchard JM
    Oncogene; 1995 Nov; 11(10):2127-34. PubMed ID: 7478533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of nuclear and cytoplasmic proteins that interact specifically with an AU-rich, cis-acting inhibitory sequence in the 3' untranslated region of human papillomavirus type 1 late mRNAs.
    Zhao C; Tan W; Sokolowski M; Schwartz S
    J Virol; 1996 Jun; 70(6):3659-67. PubMed ID: 8648700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of an mRNA destabilizing element correlates with the increased oncogenicity of proto-oncogene fos.
    Raymond V; Atwater JA; Verma IM
    Oncogene Res; 1989; 5(1):1-12. PubMed ID: 2506502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA openers and closers: modulating AU-rich element-controlled mRNA stability by a molecular switch in mRNA secondary structure.
    Meisner NC; Hackermüller J; Uhl V; Aszódi A; Jaritz M; Auer M
    Chembiochem; 2004 Oct; 5(10):1432-47. PubMed ID: 15457527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U-rich sequence-binding proteins (URBPs) interacting with a 20-nucleotide U-rich sequence in the 3' untranslated region of c-fos mRNA may be involved in the first step of c-fos mRNA degradation.
    You Y; Chen CY; Shyu AB
    Mol Cell Biol; 1992 Jul; 12(7):2931-40. PubMed ID: 1620106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of sequence-specific proteins to the 3'-untranslated region of vasoactive intestinal peptide mRNA.
    Wolford JK; Signs SA
    Biochem Biophys Res Commun; 1995 Jun; 211(3):819-25. PubMed ID: 7541199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfilament-dependent modulation of cytoplasmic protein binding to TNFalpha mRNA AU-rich instability element in human lymphoid cells.
    Henics T
    Cell Biol Int; 1999; 23(8):561-70. PubMed ID: 10704240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for recognition of AU-rich element RNA by the HuD protein.
    Wang X; Tanaka Hall TM
    Nat Struct Biol; 2001 Feb; 8(2):141-5. PubMed ID: 11175903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3' untranslated region.
    Tan W; Schwartz S
    J Virol; 1995 May; 69(5):2932-45. PubMed ID: 7707519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 3' untranslated region.
    Wiklund L; Sokolowski M; Carlsson A; Rush M; Schwartz S
    J Biol Chem; 2002 Oct; 277(43):40462-71. PubMed ID: 12147699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism.
    Winzen R; Kracht M; Ritter B; Wilhelm A; Chen CY; Shyu AB; Müller M; Gaestel M; Resch K; Holtmann H
    EMBO J; 1999 Sep; 18(18):4969-80. PubMed ID: 10487749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein.
    Zhao X; Oberg D; Rush M; Fay J; Lambkin H; Schwartz S
    J Virol; 2005 Apr; 79(7):4270-88. PubMed ID: 15767428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous nuclear ribonucleoprotein C binds exclusively to the functionally important UUUUU-motifs in the human papillomavirus type-1 AU-rich inhibitory element.
    Sokolowski M; Schwartz S
    Virus Res; 2001 Mar; 73(2):163-75. PubMed ID: 11172920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human c-fos and TNFalpha AU-rich elements show different effects on mRNA abundance and protein expression depending on the reporter in the yeast Pichia pastoris.
    Lautz T; Stahl U; Lang C
    Yeast; 2010 Jan; 27(1):1-9. PubMed ID: 19908204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs.
    Nabors LB; Gillespie GY; Harkins L; King PH
    Cancer Res; 2001 Mar; 61(5):2154-61. PubMed ID: 11280780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of cellular mRNAs and up-regulation of proteins by oligoribonucleotides homologous to the Bcl2 adenine-uridine rich element motif.
    Bevilacqua A; Ghisolfi L; Franzi S; Maresca G; Gherzi R; Capaccioli S; Nicolin A; Canti G
    Mol Pharmacol; 2007 Feb; 71(2):531-8. PubMed ID: 17077270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.